ArriVent BioPharma (AVBP) Q4 2024 Earnings

14NovConfirmed
Q2 2024
Q3 2024
Q4 2024
-1.08
-0.92
-0.77
-0.61

Details

Expected EPS
-1.002569
Actual EPS
-0.61
Surprise EPS
0.39
Surprise Percent
+39.16%

Description

ArriVent BioPharma (AVBP) has reported earnings of -0.61 per share for Q4 2024.

0 Comments

Share your thoughts